Company Filing History:
1 out of 6 
1 out of 4 
1 out of 2 Years Active: 2022-2024
Title: Innovations of Yuehua Zhou in Antibody Development
Introduction
Yuehua Zhou is a prominent inventor based in Jiangsu, China, known for his significant contributions to the field of biotechnology. He holds two patents that focus on innovative antibody technologies aimed at enhancing immune responses.
Latest Patents
One of his latest patents is the "Anti-BTLA antibody," which relates to an antibody or an antigen-binding fragment that includes specific light and heavy chain CDR domains. This invention also encompasses a nucleic acid molecule encoding the antibody, an expression vector, and a host cell, along with therapeutic applications. Another notable patent is the "Anti-PD-L1 antibody and application thereof," which describes an antibody that binds to PD-L1 with high affinity. This patent includes a nucleic acid molecule, an expression vector, and a method for producing the antibody, aimed at enhancing T cell function to treat diseases caused by T cell dysfunction.
Career Highlights
Yuehua Zhou has worked with notable companies in the biotechnology sector, including Shanghai Junshi Biosciences Co., Ltd. and Junmeng Biosciences Co., Ltd. His work in these organizations has contributed to advancements in antibody therapies.
Collaborations
Some of his coworkers include Hai Wu and Jian Yao, who have collaborated with him on various projects in the field of antibody research.
Conclusion
Yuehua Zhou's innovative work in antibody development showcases his commitment to advancing medical science and improving therapeutic options for patients. His patents reflect a deep understanding of immunology and biotechnology, positioning him as a key figure in this vital area of research.